Top

Published in:

01-10-2003 | ORIGINAL

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment

Authors: L. Priano, G. Albani, A. Brioschi, G. Guastamacchia, S. Calderoni, L. Lopiano, M. Rizzone, R. Cavalli, M. R. Gasco, F. Fraschini, B. Bergamasco, A. Mauro

Published in: Neurological Sciences | Issue 3/2003

Title: Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment
Authors: L. Priano
G. Albani
A. Brioschi
G. Guastamacchia
S. Calderoni
L. Lopiano
M. Rizzone
R. Cavalli
M. R. Gasco
F. Fraschini
B. Bergamasco
A. Mauro
Publication date: 01-10-2003
Publisher: Springer-Verlag
Published in: Neurological Sciences / Issue 3/2003
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-003-0133-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2003

123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer’s disease

Optimizing levodopa pharmacokinetics in Parkinson’s disease: the role of COMT inhibitor

Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse

Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy